Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...

Revenues increased 7.9% to $108.2 million in the third quarter of 2025 from $100.3 million in the third quarter of 2024;Organic growth of 3.5% ...

In a recent report, Knight Frank revealed that the number of auction listings in Singapore surged 47.7% q-o-q to 127 ...